156 related articles for article (PubMed ID: 36870800)
21. Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma.
Gómez León N; Delgado-Bolton RC; Del Campo Del Val L; Cabezas B; Arranz R; García M; Cannata J; González Ortega S; Pérez Sáez MÁ; López-Botet B; Rodríguez-Vigil B; Mateo M; Colletti PM; Rubello D; Carreras JL
Clin Nucl Med; 2017 Aug; 42(8):595-602. PubMed ID: 28604477
[TBL] [Abstract][Full Text] [Related]
22. Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas.
Sadik M; Lind E; Polymeri E; Enqvist O; Ulén J; Trägårdh E
Clin Physiol Funct Imaging; 2019 Jan; 39(1):78-84. PubMed ID: 30284376
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Values of Baseline
Zhou Y; Zhang X; Qin H; Zhao Z; Li J; Zhang B; Sang S; Wu Y; Deng S
Biomed Res Int; 2020; 2020():9746716. PubMed ID: 32185229
[TBL] [Abstract][Full Text] [Related]
24. TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis.
Yousefirizi F; Klyuzhin IS; O JH; Harsini S; Tie X; Shiri I; Shin M; Lee C; Cho SY; Bradshaw TJ; Zaidi H; Bénard F; Sehn LH; Savage KJ; Steidl C; Uribe CF; Rahmim A
Eur J Nucl Med Mol Imaging; 2024 Feb; ():. PubMed ID: 38326655
[TBL] [Abstract][Full Text] [Related]
25. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.
Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M
Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
27. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
Kiamanesh Z; Ayati N; Sadeghi R; Hawkes E; Lee ST; Scott AM
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4661-4676. PubMed ID: 35932329
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Yield of Body CT and Whole-Body FDG PET/CT for Initial Systemic Staging in Patients With Suspected Primary CNS Lymphoma: A Systematic Review and Meta-Analysis.
Park HY; Suh CH; Huang RY; Guenette JP; Kim HS
AJR Am J Roentgenol; 2021 May; 216(5):1172-1182. PubMed ID: 32812800
[No Abstract] [Full Text] [Related]
29. Prognostic role of baseline
Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
[TBL] [Abstract][Full Text] [Related]
30.
Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
[TBL] [Abstract][Full Text] [Related]
31. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
32. Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.
Decazes P; Becker S; Toledano MN; Vera P; Desbordes P; Jardin F; Tilly H; Gardin I
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1672-1679. PubMed ID: 29705879
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 11 automated PET segmentation methods in lymphoma.
Weisman AJ; Kieler MW; Perlman S; Hutchings M; Jeraj R; Kostakoglu L; Bradshaw TJ
Phys Med Biol; 2020 Nov; 65(23):235019. PubMed ID: 32906088
[TBL] [Abstract][Full Text] [Related]
34. Metabolic tumor burden on baseline
Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
Ponisio MR; McConathy J; Laforest R; Khanna G
Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
[TBL] [Abstract][Full Text] [Related]
36. Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
Hosch R; Weber M; Sraieb M; Flaschel N; Haubold J; Kim MS; Umutlu L; Kleesiek J; Herrmann K; Nensa F; Rischpler C; Koitka S; Seifert R; Kersting D
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4503-4515. PubMed ID: 35904589
[TBL] [Abstract][Full Text] [Related]
37. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
38. The utility of FDG-PET for managing patients with malignant lymphoma: analysis of data from a single cancer center.
Imataki O; Tamai Y; Yokoe K; Furukawa T; Kawakami K
Intern Med; 2009; 48(17):1509-13. PubMed ID: 19721294
[TBL] [Abstract][Full Text] [Related]
39. Value of baseline and end of chemotherapy
Xiao Z; Mo Y; Long W; Li R; Li X; Wei Y; Fan W; Zhang X
Leuk Lymphoma; 2021 Dec; 62(12):2873-2881. PubMed ID: 34165390
[TBL] [Abstract][Full Text] [Related]
40. PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L; Bezzi D; Nanni C; Paccagnella A; Farina A; Broccoli A; Casadei B; Zinzani PL; Fanti S
Semin Nucl Med; 2023 May; 53(3):320-351. PubMed ID: 36522191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
